Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04612751 |
Title | Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab With or Without Carboplatin in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung04) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Daiichi Sankyo, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | FRA |